Four ASX cancer stocks to watch...NAB Trade, page-4

hi Bobadah, PTX-100 is actually the dark horse in the background, a tad behind the PTX-200 trials but taking a different approach with RhoA inhibitor focus as against the PTX -200 Akt inhibitor focus (please excuse my clumsy use of medico jargon) and as you quote "the most clinically advanced RhoA inhibitor in oncology". There would be some pretty knowledgable medico boffs on this forum that put great store in its potential. Multi bag some would say. Looks like from your post yesterday that you made a pretty timely top up.